Trial Profile
Comparison of HBeAg seroconversion in Asian versus non-Asian patients with chronic hepatitis B who were treated with tenofovir (TDF) or entecavir (ETV).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 23 Dec 2015 New trial record